PET Bottles for Oral Solid Preparation Market Outlook: Pharmaceutical Primary Packaging, Tablet & Ca
公開 2026/03/27 17:12
最終更新
-
Global Leading Market Research Publisher QYResearch announces the release of its latest report “PET Bottles for Oral Solid Preparation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global PET Bottles for Oral Solid Preparation market, including market size, share, demand, industry development status, and forecasts for the next few years.
For pharmaceutical manufacturers, generic drug producers, and nutraceutical packers, the primary packaging of oral solid dosage forms—tablets and capsules—requires containers that combine mechanical strength, moisture/oxygen barrier, and regulatory compliance. Traditional packaging materials such as glass and PVC offer established performance but present trade-offs in weight, breakage risk, or environmental impact. PET bottles for oral solid preparation address these requirements with wide-mouth PET packer bottles designed specifically for primary packaging of tablets and capsules. These bottles offer mechanical strength, impact resistance, and chemical stability with adequate moisture and oxygen barrier properties under proper resin selection and processing. Available in transparent or amber formulations for light shielding, and compatible with tamper-evident and child-resistant closures, these bottles meet rigorous pharmaceutical regulatory standards. The global market for PET bottles for oral solid preparation was valued at US$ 2,232 million in 2025 and is projected to grow at a CAGR of 5.5% to reach US$ 3,224 million by 2032, driven by increasing pharmaceutical production, growth in generic and nutraceutical markets, and the ongoing shift from glass to plastic packaging. In 2024, global sales reached approximately 6.18 billion units, with an average market price of US$ 0.34 per bottle.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6096650/pet-bottles-for-oral-solid-preparation
Market Definition and Product Segmentation
PET bottles for oral solid preparation represent a specialized category within pharmaceutical packaging, distinguished by their suitability for direct contact with solid dosage forms. These wide-mouth bottles are manufactured via stretch blow molding (SBM) with cleaning and sterilization steps, ensuring product safety and regulatory compliance.
Volume Capacity Segmentation
The market is stratified by bottle capacity, each addressing distinct dosage count and prescription requirements:
Small Volume (≤50ml): The dominant segment for low-count prescriptions, travel sizes, and over-the-counter products where smaller bottle sizes match typical dispensing quantities.
Medium Volume (50–250ml): The mainstream segment for standard prescription quantities and bulk bottle sizes commonly used in retail pharmacies.
Large Volume (>250ml): Serving institutional dispensing, hospital pharmacies, and high-volume nutraceutical products requiring larger packaging formats.
Application Segmentation
The market serves critical pharmaceutical sectors:
Tablets: The largest segment, encompassing immediate-release, extended-release, and specialty tablet formulations requiring moisture and oxygen protection throughout shelf life.
Capsules: Serving gelatin and vegetarian capsules where moisture ingress can affect capsule integrity and drug stability.
Others: Including powders, granules, and other solid oral dosage forms.
Industry Value Chain and Competitive Landscape
Upstream Supply Chain
The industry relies on specialized upstream suppliers:
Bottle-Grade PET Resin: High-quality PET resins with appropriate intrinsic viscosity for pharmaceutical applications
Masterbatches: Colorants and additives for amber light-shielding and UV protection
Closures: Child-resistant, tamper-evident, and standard cap systems from specialized closure manufacturers
Midstream Manufacturing
Manufacturers utilize stretch blow molding (SBM) processes to produce bottles, incorporating cleaning and sterilization steps to meet pharmaceutical hygiene requirements. Quality systems and regulatory compliance are essential.
Downstream Customers
End-user segments include:
Multinational Pharmaceutical Companies: Global innovators requiring validated, high-quality packaging
Regional and Generic Drug Manufacturers: Volume-driven producers seeking cost-effective, reliable packaging
Nutraceutical Packers: Supplement manufacturers requiring pharmaceutical-grade packaging for consumer products
Competitive Landscape
The market features a competitive landscape combining global pharmaceutical packaging leaders with regional specialists. Key players include Gerresheimer, Amcor, AptarGroup, SGD Pharma, Origin Pharma Packaging, Weener Plastics Group, Zhejiang Gongdong Medical Technology, Shaanxi Boye Plastic, Sichuan Hui Li Industry, Shijiazhuang Zhonghui Pharmaceutical Packaging, Shijiazhuang Xinfuda Medical Packaging, Xiamen Xinxing Packaging, Zhejiang Huanuo Pharmaceutical Packaging, Shanghai Haichang Medical Plastics, and Huifeng Medical Packaging.
Industry Development Characteristics
1. Glass-to-Plastic Conversion
A case study from QYResearch's industry monitoring reveals that the pharmaceutical industry continues converting from glass to PET for oral solid preparations. PET offers significant advantages: weight reduction (50-70% lighter than glass), elimination of breakage risk, lower transportation costs, and improved safety for patients. For many solid oral dosage forms, PET's barrier properties now meet stability requirements previously achievable only with glass.
2. Child-Resistant and Tamper-Evident Features
Regulatory requirements for child-resistant (CR) and tamper-evident (TE) closures have become standard for many prescription and OTC products. A case study from the pharmaceutical packaging sector indicates that manufacturers offering integrated PET bottles with certified CR/TE closure systems capture premium positioning and simplify qualification for pharmaceutical customers.
3. Moisture and Oxygen Barrier Optimization
Barrier performance is critical for moisture-sensitive and oxygen-sensitive drugs. A case study from the packaging technology sector indicates that optimized PET resins, multilayer structures, and barrier coatings enable PET bottles to achieve shelf life comparable to glass for an expanding range of drug products.
4. Light-Shielding Capabilities
Amber PET bottles provide UV and visible light protection for light-sensitive drugs. A case study from the pharmaceutical formulation sector indicates that amber PET offers effective light protection while maintaining recyclability and processability advantages over alternative materials.
Exclusive Industry Insights: The Sustainability Transition
Our proprietary analysis identifies sustainability as an emerging market driver. PET bottles are widely recyclable, and pharmaceutical companies increasingly specify recycled content (rPET) where approved for drug packaging. Manufacturers investing in rPET capabilities and demonstrating reduced environmental footprint capture preference from environmentally conscious pharmaceutical customers.
Strategic Outlook
For industry executives, investors, and marketing leaders evaluating opportunities in the PET bottles for oral solid preparation market, the projected 5.5% CAGR reflects sustained demand from pharmaceutical production growth, glass-to-plastic conversion, and generic market expansion. Manufacturers positioned to capture disproportionate share share three characteristics: demonstrated expertise in pharmaceutical-grade PET processing and quality systems; product portfolios spanning small, medium, and large volume capacities; and established relationships with multinational pharma, generic manufacturers, and nutraceutical packers. As the market evolves toward enhanced barrier performance, sustainable materials, and integrated closure solutions, the ability to deliver reliable, compliant, and innovative packaging will define competitive leadership.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
For pharmaceutical manufacturers, generic drug producers, and nutraceutical packers, the primary packaging of oral solid dosage forms—tablets and capsules—requires containers that combine mechanical strength, moisture/oxygen barrier, and regulatory compliance. Traditional packaging materials such as glass and PVC offer established performance but present trade-offs in weight, breakage risk, or environmental impact. PET bottles for oral solid preparation address these requirements with wide-mouth PET packer bottles designed specifically for primary packaging of tablets and capsules. These bottles offer mechanical strength, impact resistance, and chemical stability with adequate moisture and oxygen barrier properties under proper resin selection and processing. Available in transparent or amber formulations for light shielding, and compatible with tamper-evident and child-resistant closures, these bottles meet rigorous pharmaceutical regulatory standards. The global market for PET bottles for oral solid preparation was valued at US$ 2,232 million in 2025 and is projected to grow at a CAGR of 5.5% to reach US$ 3,224 million by 2032, driven by increasing pharmaceutical production, growth in generic and nutraceutical markets, and the ongoing shift from glass to plastic packaging. In 2024, global sales reached approximately 6.18 billion units, with an average market price of US$ 0.34 per bottle.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6096650/pet-bottles-for-oral-solid-preparation
Market Definition and Product Segmentation
PET bottles for oral solid preparation represent a specialized category within pharmaceutical packaging, distinguished by their suitability for direct contact with solid dosage forms. These wide-mouth bottles are manufactured via stretch blow molding (SBM) with cleaning and sterilization steps, ensuring product safety and regulatory compliance.
Volume Capacity Segmentation
The market is stratified by bottle capacity, each addressing distinct dosage count and prescription requirements:
Small Volume (≤50ml): The dominant segment for low-count prescriptions, travel sizes, and over-the-counter products where smaller bottle sizes match typical dispensing quantities.
Medium Volume (50–250ml): The mainstream segment for standard prescription quantities and bulk bottle sizes commonly used in retail pharmacies.
Large Volume (>250ml): Serving institutional dispensing, hospital pharmacies, and high-volume nutraceutical products requiring larger packaging formats.
Application Segmentation
The market serves critical pharmaceutical sectors:
Tablets: The largest segment, encompassing immediate-release, extended-release, and specialty tablet formulations requiring moisture and oxygen protection throughout shelf life.
Capsules: Serving gelatin and vegetarian capsules where moisture ingress can affect capsule integrity and drug stability.
Others: Including powders, granules, and other solid oral dosage forms.
Industry Value Chain and Competitive Landscape
Upstream Supply Chain
The industry relies on specialized upstream suppliers:
Bottle-Grade PET Resin: High-quality PET resins with appropriate intrinsic viscosity for pharmaceutical applications
Masterbatches: Colorants and additives for amber light-shielding and UV protection
Closures: Child-resistant, tamper-evident, and standard cap systems from specialized closure manufacturers
Midstream Manufacturing
Manufacturers utilize stretch blow molding (SBM) processes to produce bottles, incorporating cleaning and sterilization steps to meet pharmaceutical hygiene requirements. Quality systems and regulatory compliance are essential.
Downstream Customers
End-user segments include:
Multinational Pharmaceutical Companies: Global innovators requiring validated, high-quality packaging
Regional and Generic Drug Manufacturers: Volume-driven producers seeking cost-effective, reliable packaging
Nutraceutical Packers: Supplement manufacturers requiring pharmaceutical-grade packaging for consumer products
Competitive Landscape
The market features a competitive landscape combining global pharmaceutical packaging leaders with regional specialists. Key players include Gerresheimer, Amcor, AptarGroup, SGD Pharma, Origin Pharma Packaging, Weener Plastics Group, Zhejiang Gongdong Medical Technology, Shaanxi Boye Plastic, Sichuan Hui Li Industry, Shijiazhuang Zhonghui Pharmaceutical Packaging, Shijiazhuang Xinfuda Medical Packaging, Xiamen Xinxing Packaging, Zhejiang Huanuo Pharmaceutical Packaging, Shanghai Haichang Medical Plastics, and Huifeng Medical Packaging.
Industry Development Characteristics
1. Glass-to-Plastic Conversion
A case study from QYResearch's industry monitoring reveals that the pharmaceutical industry continues converting from glass to PET for oral solid preparations. PET offers significant advantages: weight reduction (50-70% lighter than glass), elimination of breakage risk, lower transportation costs, and improved safety for patients. For many solid oral dosage forms, PET's barrier properties now meet stability requirements previously achievable only with glass.
2. Child-Resistant and Tamper-Evident Features
Regulatory requirements for child-resistant (CR) and tamper-evident (TE) closures have become standard for many prescription and OTC products. A case study from the pharmaceutical packaging sector indicates that manufacturers offering integrated PET bottles with certified CR/TE closure systems capture premium positioning and simplify qualification for pharmaceutical customers.
3. Moisture and Oxygen Barrier Optimization
Barrier performance is critical for moisture-sensitive and oxygen-sensitive drugs. A case study from the packaging technology sector indicates that optimized PET resins, multilayer structures, and barrier coatings enable PET bottles to achieve shelf life comparable to glass for an expanding range of drug products.
4. Light-Shielding Capabilities
Amber PET bottles provide UV and visible light protection for light-sensitive drugs. A case study from the pharmaceutical formulation sector indicates that amber PET offers effective light protection while maintaining recyclability and processability advantages over alternative materials.
Exclusive Industry Insights: The Sustainability Transition
Our proprietary analysis identifies sustainability as an emerging market driver. PET bottles are widely recyclable, and pharmaceutical companies increasingly specify recycled content (rPET) where approved for drug packaging. Manufacturers investing in rPET capabilities and demonstrating reduced environmental footprint capture preference from environmentally conscious pharmaceutical customers.
Strategic Outlook
For industry executives, investors, and marketing leaders evaluating opportunities in the PET bottles for oral solid preparation market, the projected 5.5% CAGR reflects sustained demand from pharmaceutical production growth, glass-to-plastic conversion, and generic market expansion. Manufacturers positioned to capture disproportionate share share three characteristics: demonstrated expertise in pharmaceutical-grade PET processing and quality systems; product portfolios spanning small, medium, and large volume capacities; and established relationships with multinational pharma, generic manufacturers, and nutraceutical packers. As the market evolves toward enhanced barrier performance, sustainable materials, and integrated closure solutions, the ability to deliver reliable, compliant, and innovative packaging will define competitive leadership.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
最近の記事
タグ